ORIGINAL RESEARCH article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1622865

C-reactive protein induced T cell activation is an indirect monocyte-dependent mechanism involving the CD80/CD28 pathway

Provisionally accepted
Julia  ThomeJulia Thome1*Julia  LimmerJulia Limmer1,2Teresa Zoe  BroseTeresa Zoe Brose1Johannes  ZellerJohannes Zeller1Nina  ChevalierNina Chevalier3Anna-Lena  SchäferAnna-Lena Schäfer3Laura  SchneiderLaura Schneider1Maike  LindMaike Lind1Thierry  ChristmannThierry Christmann1Marie  DreckMarie Dreck1Sheena  KreuzalerSheena Kreuzaler1David  BraigDavid Braig1Karlheinz  PeterKarlheinz Peter4Franziska  PankratzFranziska Pankratz1Steffen  Ulrich EisenhardtSteffen Ulrich Eisenhardt1
  • 1Department of Plastic and Hand Surgery, University of Freiburg Medical Center, Freiburg, Germany
  • 2University of Freiburg Medical Center, Department of Dermatology, Freiburg, Germany
  • 3Department of Rheumatology and Clinical Immunology, University of Freiburg Medical Center, Freiburg, Germany
  • 4Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

The final, formatted version of the article will be published soon.

Introduction: T cells are major components of the immune system. Their activation requires interaction between the T cell receptor and co-stimulatory molecules, crucial during infection, inflammation, and allogeneic rejection. Monomeric CRP (mCRP) is a known modulator of inflammation and particularly the innate immune response, however its interaction with T cells as part of the adaptive immune response remains unclear. Methods: Peripheral blood mononuclear cells (PBMC) and T cells were isolated. Flow cytometric analysis was conducted to evaluate Fcg receptor CD16 expression on T cells, the binding of CRP to T cells, and its impact on proliferation and apoptosis. T cell activation was assessed after 1, 2, 3, 5 and 7 days by assessing CD69 and CD25 expression, and under various conditions including coculture with monocytes and several inhibitory factors. Results: T cells express CD16 that binds mCRP in a concentration-dependent manner, and particularly on activated T cells. While mCRP reduces apoptosis and accelerates proliferation in T cells, it does not independently activate them. However, activation of monocytes by mCRP leads to T cell activation, indicating a direct cell to cell interaction during CRP-induced activation. This effect could be alleviated by inhibition of the CD80/CD28 pathway. Conclusion: CRP does not activate T Cells directly but via PI3-kinase-dependent activation of monocytes and subsequent CD80/CD28 cell to cell contact. The findings suggest the effects of CRP on T cells depend on their environment and the presence of other proinflammatory agents.

Keywords: C-Reactive Protein, T cells, Monocytes, CD80/CD28 pathway, Belatacept, innate immunity

Received: 04 May 2025; Accepted: 26 Jun 2025.

Copyright: © 2025 Thome, Limmer, Brose, Zeller, Chevalier, Schäfer, Schneider, Lind, Christmann, Dreck, Kreuzaler, Braig, Peter, Pankratz and Eisenhardt. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Julia Thome, Department of Plastic and Hand Surgery, University of Freiburg Medical Center, Freiburg, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.